| dc.contributor.author | Citterio, F | |
| dc.contributor.author | Chapman, J | |
| dc.date.accessioned | 2018-05-09T09:04:36Z | |
| dc.date.issued | 2010-11-21 | |
| dc.description.abstract | n/a | en_GB |
| dc.description.sponsorship | Jeremy Chapman Received an honorarium and travel support to attend the meeting. He is a member of Advisory Boards for Novartis, Wyeth and Astellas Pharmaceutical companies. Franco Citterio received an honorarium and travel support to attend the meeting. | en_GB |
| dc.identifier.citation | Vol. 42 (9), pp. S1 - | en_GB |
| dc.identifier.doi | 10.1016/j.transproceed.2010.09.018 | |
| dc.identifier.other | S0041-1345(10)01344-8 | |
| dc.identifier.uri | http://hdl.handle.net/10871/32770 | |
| dc.language.iso | en | en_GB |
| dc.publisher | Elsevier | en_GB |
| dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/21095442 | en_GB |
| dc.rights | Copyright © 2010 Elsevier Inc. All rights reserved. | en_GB |
| dc.subject | Congresses as Topic | en_GB |
| dc.subject | Forecasting | en_GB |
| dc.subject | Graft Survival | en_GB |
| dc.subject | Humans | en_GB |
| dc.subject | Immunosuppression | en_GB |
| dc.subject | Immunosuppressive Agents | en_GB |
| dc.subject | Kidney Transplantation | en_GB |
| dc.subject | Time Factors | en_GB |
| dc.subject | Treatment Outcome | en_GB |
| dc.title | Preface. Renal Transplantation--new insights for a new decade. | en_GB |
| dc.type | Article | en_GB |
| dc.date.available | 2018-05-09T09:04:36Z | |
| dc.identifier.issn | 0041-1345 | |
| exeter.place-of-publication | United States | en_GB |
| dc.description | This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this record. | en_GB |
| dc.identifier.journal | Transplantation Proceedings | en_GB |
